New therapeutic targets in HCC: Reptin ATPase and HCC senescence

Journal of Hepatology

Volumn 52, Issue 5, 2010, Pages 633-634

  Berasain, Carmen ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BINDING PROTEIN; DOXYCYCLINE; PONTIN; REPTIN; SHORT HAIRPIN RNA; SORAFENIB; TELOMERASE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL AGING; DRUG TARGETING; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GENE SILENCING; HEPATOMA CELL; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; DNA HELICASES; HUMANS; LIVER NEOPLASMS; PROGNOSIS;

EID: 77951623419     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.020     Document Type: Editorial

References (13)

1. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
2. Collado M., and Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10 (2010) 51-57
3. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
4. Ménard L., Taras D., Grigoletto A., Haurie V., Nicou A., Dugot-Senant N., et al. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence. J Hepatol 52 (2010) 681-689
5. Avila M.A., Berasain C., Sangro B., and Prieto J. New therapies for hepatocellular carcinoma. Oncogene 25 (2006) 3866-3884
6. Kerr S.H., and Kerr D.J. Novel treatments for hepatocellular cancer. Cancer Lett 286 (2009) 114-120
7. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (2008) 378-390
8. Ozturk M., Arslan-Ergul A., Bagislar S., Senturk S., and Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett 286 (2009) 103-113
9. Venteicher A.S., Meng Z., Mason P.J., Veenstra T.D., and Artandi S.E. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 132 (2008) 945-957
10. Jha S., and Dutta A. RVB1/RVB2: running rings around molecular biology. Mol Cell 34 (2009) 521-533
11. Huber O., Ménard L., Haurie V., Nicou A., Taras D., and Rosenbaum J. Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res 68 (2008) 6873-6876
12. Haurie V., Ménard L., Nicou A., Touriol C., Metzler P., Fernandez J., et al. Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Hepatology 50 (2009) 1871-1883
13. Rousseau B., Ménard L., Haurie V., Taras D., Blanc J.F., Moreau-Gaudry F., et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 46 (2007) 1108-1118